Skip to main navigation Skip to search Skip to main content

A Phase 1a/1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of BG-75202, Alone and in Combination with Other Agents, in Patients with Myeloid Malignancies

Project: Research

Project Details

StatusActive
Effective start/end date3/08/262/08/31

Clinical Trial Phase

  • Phase I